ASSOCIATE PROF. DR. MARNIZA BINTI SAAD
Dean Office
Faculty of Medicine
marnizaum.edu.myView CV | |
Publons | |
Scopus Link | |
Biography | |
Marniza Saad is a Consultant Clinical Oncologist at the Department of Clinical Oncology, University Malaya Medical Centre (UMMC) Kuala Lumpur, Malaysia, since 2006. She also holds the Associate Professor post at the Faculty of Medicine, University Malaya (UM) Kuala Lumpur. She obtained her Medical Degree from University of Wales College of Medicine, Cardiff, United Kingdom in 1997. She completed her general medical training within the South Wales Medical Rotation in 2000. In 2001 she joined UM as a trainee lecturer in Oncology. She pursued her formal training as clinical oncologist at the Velindre Cancer Centre in Cardiff, UK from 2002 to 2006 and was awarded the Fellowship of Royal College of Radiologists (Clinical Oncology) in 2006. She is now the supervisor and internal examiner for the Master of Clinical Oncology programme in UM since May 2006. Working within the department Education Committee, she has deep passion for education and training of future oncologists in Malaysia. She was the Head of Department of Clinical Oncology UMMC from 2013 to 2015. During this time she was overseeing the development of Stereotactic Radiosurgery/Radiotherapy (SRS/SRT) and Intensity Modulated Radiotherapy (IMRT) with the designated expert teams, until successful initiation of the services in UMMC in May and September 2015, respectively. She is currently in the UMMC Intra-Operative Radiotherapy Working Group to introduce the service in UMMC in the near future. She is an Exco Committee member for Malaysia Oncological Society since 2013. She is a member of College of Radiology Academy of Medicine Malaysia and European Society for Medical Oncology. Her areas of special interest include genitourinary cancer, sarcoma, breast and gastrointestinal cancers. She is the principle investigator for several international clinical trials mainly in urological cancers and regularly speaks in the areas of her interest at both local and international conferences. |
Publication
Finance
Efficacy and safety of therapies for advanced prostate cancer in Asia: Evidence from a systematic literature review
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer
Association Between Adherence to Clinical Practice Guidelines for Adjuvant Therapy for Breast Cancer and Survival in a Resource-Limited Setting
Managing advanced prostate cancer in the Asia Pacific region: “Real-world” application of Advanced Prostate Cancer Consensus Conference 2019 statements
Resistance of renal cell carcinoma to targeted therapy
AR-V7 in Asian patientts with metastatic CRPC : A multinational, multicentre study.
Abiraterone in metastatic castrate resistant prostate cancer: outcome and tolerance in real-world setting.
Efficacy and safety of pazopanib in advanced renal cell carcinoma treated at University Malaya Medical Centre (UMMC).
Real-World experience with abiraterone in metastatic castrate resistant prostate carcinoma in University Malaya Medical Centre.